JP2024037864A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024037864A5 JP2024037864A5 JP2023209915A JP2023209915A JP2024037864A5 JP 2024037864 A5 JP2024037864 A5 JP 2024037864A5 JP 2023209915 A JP2023209915 A JP 2023209915A JP 2023209915 A JP2023209915 A JP 2023209915A JP 2024037864 A5 JP2024037864 A5 JP 2024037864A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- human
- rpe
- rpe cells
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025120956A JP2025161815A (ja) | 2011-11-14 | 2025-07-18 | ヒトｒｐｅ細胞医薬品およびその使用 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161559521P | 2011-11-14 | 2011-11-14 | |
| US61/559,521 | 2011-11-14 | ||
| US201261589741P | 2012-01-23 | 2012-01-23 | |
| US61/589,741 | 2012-01-23 | ||
| US201261724047P | 2012-11-08 | 2012-11-08 | |
| US61/724,047 | 2012-11-08 | ||
| JP2019098508A JP6899865B2 (ja) | 2011-11-14 | 2019-05-27 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2021049493A JP7081016B2 (ja) | 2011-11-14 | 2021-03-24 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2022084915A JP7404441B2 (ja) | 2011-11-14 | 2022-05-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022084915A Division JP7404441B2 (ja) | 2011-11-14 | 2022-05-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120956A Division JP2025161815A (ja) | 2011-11-14 | 2025-07-18 | ヒトｒｐｅ細胞医薬品およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024037864A JP2024037864A (ja) | 2024-03-19 |
| JP2024037864A5 true JP2024037864A5 (enExample) | 2024-08-22 |
| JP7716463B2 JP7716463B2 (ja) | 2025-07-31 |
Family
ID=47470610
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014541421A Active JP6506023B2 (ja) | 2011-11-14 | 2012-11-14 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2017183914A Active JP6563996B2 (ja) | 2011-11-14 | 2017-09-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2019098508A Active JP6899865B2 (ja) | 2011-11-14 | 2019-05-27 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2021049493A Active JP7081016B2 (ja) | 2011-11-14 | 2021-03-24 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2022084915A Active JP7404441B2 (ja) | 2011-11-14 | 2022-05-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2023209915A Active JP7716463B2 (ja) | 2011-11-14 | 2023-12-13 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2025120956A Pending JP2025161815A (ja) | 2011-11-14 | 2025-07-18 | ヒトｒｐｅ細胞医薬品およびその使用 |
Family Applications Before (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014541421A Active JP6506023B2 (ja) | 2011-11-14 | 2012-11-14 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2017183914A Active JP6563996B2 (ja) | 2011-11-14 | 2017-09-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2019098508A Active JP6899865B2 (ja) | 2011-11-14 | 2019-05-27 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2021049493A Active JP7081016B2 (ja) | 2011-11-14 | 2021-03-24 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2022084915A Active JP7404441B2 (ja) | 2011-11-14 | 2022-05-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120956A Pending JP2025161815A (ja) | 2011-11-14 | 2025-07-18 | ヒトｒｐｅ細胞医薬品およびその使用 |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US20130195806A1 (enExample) |
| EP (2) | EP3563860A1 (enExample) |
| JP (7) | JP6506023B2 (enExample) |
| KR (1) | KR102054904B1 (enExample) |
| CN (2) | CN113786417A (enExample) |
| AU (5) | AU2012340020A1 (enExample) |
| CA (2) | CA2855941A1 (enExample) |
| CY (1) | CY1121819T1 (enExample) |
| DK (1) | DK2780022T4 (enExample) |
| ES (1) | ES2734453T3 (enExample) |
| FI (1) | FI2780022T4 (enExample) |
| GB (1) | GB2496969A (enExample) |
| HK (1) | HK1202456A1 (enExample) |
| HR (1) | HRP20191110T1 (enExample) |
| HU (1) | HUE044778T2 (enExample) |
| IL (5) | IL308205B2 (enExample) |
| LT (1) | LT2780022T (enExample) |
| PL (1) | PL2780022T3 (enExample) |
| PT (1) | PT2780022T (enExample) |
| RS (1) | RS59050B1 (enExample) |
| SI (1) | SI2780022T1 (enExample) |
| TW (5) | TW202434266A (enExample) |
| WO (1) | WO2013074681A1 (enExample) |
Families Citing this family (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7794704B2 (en) | 2004-01-23 | 2010-09-14 | Advanced Cell Technology, Inc. | Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration |
| EP2438814A3 (en) * | 2004-01-23 | 2012-10-03 | Advanced Cell Technology, Inc. | Improved modalities for the treatment of degenerative diseases of the retina |
| DK2209888T3 (da) | 2007-10-12 | 2020-01-20 | Astellas Inst For Regenerative Medicine | Forbedrede fremgangsmåder til fremstilling af rpe-celler og sammensætninger af rpe-celler |
| KR20120102709A (ko) | 2009-11-17 | 2012-09-18 | 어드밴스드 셀 테크놀로지, 인코포레이티드 | 인간 ｒｐｅ 세포의 생산 방법 및 인간 ｒｐｅ 세포의 제약 제제 |
| US10852069B2 (en) | 2010-05-04 | 2020-12-01 | Fractal Heatsink Technologies, LLC | System and method for maintaining efficiency of a fractal heat sink |
| WO2012012803A2 (en) | 2010-07-23 | 2012-01-26 | Advanced Cell Technology, Inc. | Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
| US10676780B2 (en) | 2011-09-26 | 2020-06-09 | Qiagen Gmbh | Stabilisation and isolation of extracellular nucleic acids |
| EP4397770A1 (en) | 2011-09-26 | 2024-07-10 | PreAnalytiX GmbH | Stabilisation and isolation of extracellular nucleic acids |
| US11021733B2 (en) | 2011-09-26 | 2021-06-01 | Qiagen Gmbh | Stabilization and isolation of extracellular nucleic acids |
| TW202434266A (zh) * | 2011-11-14 | 2024-09-01 | 安斯泰來再生醫藥協會 | 人類rpe細胞之醫藥組合物及其用途 |
| CA2884915C (en) | 2012-09-25 | 2022-05-17 | Qiagen Gmbh | Stabilisation of biological samples |
| EP3323884A1 (en) | 2013-02-01 | 2018-05-23 | The United States Of America as Represented by the Secretary, Department of Health an Human Service | Method for generating retinal pigment epithelium (rpe) cells from induced pluripotent stem cells (ipscs) |
| CN105283550A (zh) | 2013-03-18 | 2016-01-27 | 凯杰有限公司 | 生物样品的稳定化 |
| CN105121643A (zh) | 2013-03-18 | 2015-12-02 | 凯杰有限公司 | 细胞外核酸的稳定化和分离 |
| ES2763433T3 (es) | 2013-11-27 | 2020-05-28 | Kyoto Prefectural Public Univ Corp | Aplicación de laminina a cultivos de células endoteliales de la córnea |
| EP3080248A1 (en) | 2013-12-11 | 2016-10-19 | Pfizer Limited | Method for producing retinal pigment epithelial cells |
| CN106102766A (zh) * | 2014-01-22 | 2016-11-09 | 皮埃尔与玛丽·居里大学 - 巴黎第六大学 | 用于治疗视网膜炎症的试剂 |
| EP2898896A1 (en) * | 2014-01-22 | 2015-07-29 | Université Pierre et Marie Curie (Paris 6) | Agents for use in the treatment of retinal inflammation |
| JP6664332B2 (ja) * | 2014-03-18 | 2020-03-13 | キアゲン ゲーエムベーハー | 細胞外核酸の安定化および単離 |
| WO2015175504A1 (en) * | 2014-05-12 | 2015-11-19 | The Johns Hopkins University | Differentiation of human pluripotent stem cells into retinal pigment epithelium using hif1 inhibitors |
| US10457915B2 (en) | 2014-05-15 | 2019-10-29 | International Stem Cell Corporation | Chemical differentiation of pluripotentstem cells into retinal epithelial cells |
| US10597633B2 (en) | 2014-05-16 | 2020-03-24 | Koninklijke Nederlandse Akademie Van Wetenschappen | Culture method for organoids |
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| US20160095307A1 (en) | 2014-10-07 | 2016-04-07 | NuTech Medical, Inc. | Method and composition for hypothermic storage of placental tissue |
| JP6849590B2 (ja) | 2014-10-17 | 2021-03-24 | コディアック サイエンシーズ インコーポレイテッドＫｏｄｉａｋ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． | ブチリルコリンエステラーゼ両性イオン性ポリマーコンジュゲート |
| EP3213761B1 (en) * | 2014-10-31 | 2021-05-19 | Kyoto Prefectural Public University Corporation | Novel treatment of retina using laminin |
| MX387839B (es) * | 2014-10-31 | 2025-03-04 | Senju Pharma Co | Laminina para usarse en el tratamiento de una enfermedad, un trastorno o una afección de un endotelio de córnea. |
| EP3233093B1 (en) * | 2014-12-18 | 2022-06-29 | Sorbonne Universite | Transgenic rpe cells overexpressing otx2 for the treatment of retinal degeneration |
| CA2972700A1 (en) * | 2014-12-30 | 2016-07-07 | Cell Cure Neurosciences Ltd. | Methods of treating retinal diseases |
| MX2017008737A (es) * | 2014-12-30 | 2018-01-25 | Cell Cure Neurosciences Ltd | Poblaciones de celulas rpe y metodos para generar las mismas. |
| EP3916085A1 (en) | 2014-12-30 | 2021-12-01 | Cell Cure Neurosciences Ltd. | Assessing retinal pigment epithelial cell populations |
| CA2980580C (en) * | 2015-03-23 | 2024-01-23 | Astellas Institute For Regenerative Medicine | Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors |
| CN105013010B (zh) * | 2015-07-07 | 2018-01-12 | 中山大学中山眼科中心 | 一种辅助iPS‑RPE移植的层粘连蛋白膜 |
| DK3331994T3 (da) | 2015-08-05 | 2022-11-21 | Cell Cure Neurosciences Ltd | Fremstilling af retinale pigmentepitelceller |
| WO2017031312A1 (en) | 2015-08-18 | 2017-02-23 | Astellas Institute For Regenerative Medicine | Clinical formulations |
| EP4001402A1 (en) * | 2015-09-08 | 2022-05-25 | FUJIFILM Cellular Dynamics, Inc. | Macs-based purification of stem cell-derived retinal pigment epithelium |
| CA3005694A1 (en) | 2015-11-20 | 2017-05-26 | Qiagen Gmbh | Method of preparing sterilized compositions for stabilization of extracellular nucleic acids |
| BR112018013407A2 (en) | 2015-12-30 | 2018-12-18 | Kodiak Sciences Inc. | antibodies and conjugates thereof |
| GB201603569D0 (en) | 2016-03-01 | 2016-04-13 | Koninklijke Nederlandse Akademie Van Wetenschappen | Improved differentiation method |
| CN106420809B (zh) * | 2016-08-31 | 2017-08-08 | 浙江济民制药股份有限公司 | 一种眼科手术灌注液 |
| US12215349B2 (en) * | 2016-12-13 | 2025-02-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of preparing an isolated or purified population of thymic emigrant cells and methods of treatment using same |
| EP3824906A1 (en) | 2016-12-21 | 2021-05-26 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| US11076984B2 (en) * | 2017-03-13 | 2021-08-03 | Gyroscope Therapeutics Limited | Method of performing subretinal drainage and agent delivery |
| KR20200031559A (ko) * | 2017-03-16 | 2020-03-24 | 리니지 셀 테라퓨틱스, 인크. | 망막 질환 요법의 치료 효과를 측정하는 방법 |
| US11759438B2 (en) | 2017-05-01 | 2023-09-19 | The Board Of Supervisors Of Louisiana State | Compositions and methods for treating ocular pathologies |
| GB201721615D0 (en) | 2017-12-21 | 2018-02-07 | Koninklijke Nederlandse Akademie Van Wetenschappen | Immune cell organoid co-cultures |
| KR20240161220A (ko) * | 2017-12-29 | 2024-11-12 | 셀 큐어 뉴로사이언시스 리미티드 | 망막 색소 상피 세포 조성물 |
| US12029683B2 (en) | 2018-02-22 | 2024-07-09 | Alcon Inc. | Ocular implant and delivery system |
| SG11202008242XA (en) * | 2018-03-02 | 2020-09-29 | Kodiak Sciences Inc | Il-6 antibodies and fusion constructs and conjugates thereof |
| CN113226387B (zh) * | 2018-11-19 | 2024-02-23 | 美国政府(由卫生和人类服务部的部长所代表) | 可生物降解的组织置换植入物及其用途 |
| GB201819224D0 (en) | 2018-11-26 | 2019-01-09 | Koninklijke Nederlandse Akademie Van Wetenschappen | Hepatocyte expansion methods |
| MX2021006646A (es) * | 2018-12-05 | 2021-12-10 | Abeona Therapeutics Inc | Vector viral adenoasociado recombinante para el suministro de genes. |
| CN113874494A (zh) * | 2019-05-28 | 2021-12-31 | 豪夫迈·罗氏有限公司 | 产生单核细胞祖细胞的方法 |
| KR20250051157A (ko) | 2019-06-05 | 2025-04-16 | 리제너론 파아마슈티컬스, 인크. | 정밀 투여량 전달을 위한 디바이스 및 방법 |
| KR102198942B1 (ko) * | 2019-07-02 | 2021-01-05 | 의료법인 성광의료재단 | Pedf를 발현하거나 모세포에 비하여 pedf를 과발현하도록 유전적으로 조작된 중간엽 줄기세포 |
| EP4013297A4 (en) | 2019-08-16 | 2023-12-13 | Poltorak Technologies, LLC | DEVICE AND METHOD FOR MEDICAL DIAGNOSTICS |
| US11912784B2 (en) | 2019-10-10 | 2024-02-27 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| IL292610A (en) | 2019-10-30 | 2022-07-01 | Astellas Inst For Regenerative Medicine | Methods for the production of retinal pigment epithelial cells |
| EP4061942A4 (en) * | 2019-11-22 | 2023-12-20 | Sigilon Therapeutics, Inc. | MONOCLONAL CELL LINES EXPRESSING AN EXOGENEOUS SUBSTANCE AND THEIR USES |
| US12433289B2 (en) | 2020-01-21 | 2025-10-07 | Takeda Pharmaceutical Company Limited | Compositions and methods of cryopreserving cells |
| CN115485024A (zh) * | 2020-02-07 | 2022-12-16 | 纽约市哥伦比亚大学理事会 | 重编程代谢组以延迟发病或治疗神经变性 |
| TW202216158A (zh) * | 2020-07-10 | 2022-05-01 | 國立研究開發法人理化學研究所 | 網膜色素上皮細胞之移植用存活促進劑 |
| CN112544612A (zh) * | 2020-12-18 | 2021-03-26 | 江苏艾尔康生物医药科技有限公司 | 冻存液及其在rpe细胞冻存中的应用 |
| CN112834411B (zh) * | 2021-01-07 | 2022-05-27 | 上海交通大学 | 应用于质谱流式技术的金属纳米探针及制备方法和应用 |
| CN112926116B (zh) * | 2021-03-01 | 2023-02-17 | 哈尔滨工业大学 | 一种基于虚拟现实的体育馆火灾疏散行为数据收集系统及其收集方法 |
| CN114246938A (zh) * | 2022-01-25 | 2022-03-29 | 中山大学中山眼科中心 | Il-4在制备用于治疗视网膜变性疾病药物中的应用 |
| WO2023149420A1 (ja) * | 2022-02-01 | 2023-08-10 | 株式会社坪田ラボ | 近視を予防または治療するための方法および組成物 |
| CN114561356B (zh) * | 2022-03-09 | 2022-09-13 | 北京呈诺医学科技有限公司 | 影响细胞因子分泌的方法及应用 |
| JPWO2023176906A1 (enExample) * | 2022-03-16 | 2023-09-21 | ||
| WO2024218311A1 (fr) * | 2023-04-21 | 2024-10-24 | Pulsesight Therapeutics | Compositions à base de décorine pour la réparation et la régéneration de l'épithélium pigmentaire de la rétine |
| KR20260004514A (ko) * | 2023-05-05 | 2026-01-08 | 더 리전츠 오브 더 유니버시티 오브 캘리포니아 | 망막 색소 상피 세포 요법 |
| CN117625536B (zh) * | 2024-01-26 | 2024-04-30 | 中国人民解放军总医院第三医学中心 | 一种人视网膜色素上皮细胞的纯化、培养方法 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4138205A (en) | 1975-12-15 | 1979-02-06 | Hydro Pulse Corporation | Movable stator walls permitting access to tubing in peristaltic pump |
| US5610753A (en) | 1991-12-12 | 1997-03-11 | Eastman Kodak Company | Optical design of laser scanner to reduce thermal sensitivity |
| GB9608145D0 (en) * | 1996-04-19 | 1996-06-26 | British Tech Group | Wound healing |
| US20040086494A1 (en) * | 1996-10-07 | 2004-05-06 | John Constance Mary | Immune privileged cells for delivery of proteins and peptides |
| US5998423A (en) | 1996-10-08 | 1999-12-07 | Therasys, Inc. | Methods for modulating melanin production |
| WO1999012572A1 (en) | 1997-09-10 | 1999-03-18 | University Of Florida | Compounds and method for the prevention and treatment of diabetic retinopathy |
| KR20010033834A (ko) * | 1998-01-02 | 2001-04-25 | 타이탄 파마슈티칼스 인코퍼레이티드 | 면역 특권 부위의 생성을 위한 착색된 망막 상피 세포의사용 |
| US7410798B2 (en) | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
| US6943153B1 (en) | 1999-03-15 | 2005-09-13 | The Regents Of The University Of California | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| US6331313B1 (en) | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
| US6576422B1 (en) * | 2000-10-17 | 2003-06-10 | Rohm And Haas Company | Method for identifying products employing gene expression |
| WO2002043785A2 (en) | 2000-11-29 | 2002-06-06 | Oculex Pharmaceuticals, Inc. | Intraocular implants for preventing transplant rejection in the eye |
| JP2004535792A (ja) * | 2001-04-27 | 2004-12-02 | ザ ジェネラル ホスピタル コーポレーション | チロシナーゼアッセイ法 |
| CA2455499C (en) * | 2001-08-08 | 2011-06-21 | The Trustees Of The University Of Pennsylvania | Method for purification of viral vectors having proteins which bind sialic acid |
| MXPA04005010A (es) | 2001-11-26 | 2005-04-08 | Advanced Cell Tech Inc | METODO PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS METODOS PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS HUMANOS REPROGRAMADOS Y CELULAS DEL TALLO HUMANAS AUTOLOGAS E ISOGENICAS. |
| CA2473909A1 (en) | 2002-01-15 | 2003-07-24 | Advanced Cell Technology, Inc. | Cloning b and t lymphocytes |
| US20040091936A1 (en) | 2002-05-24 | 2004-05-13 | Michael West | Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank |
| US7803750B2 (en) | 2002-07-29 | 2010-09-28 | Duke University | Method of modulating melanin production |
| US7794704B2 (en) * | 2004-01-23 | 2010-09-14 | Advanced Cell Technology, Inc. | Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration |
| EP2438814A3 (en) | 2004-01-23 | 2012-10-03 | Advanced Cell Technology, Inc. | Improved modalities for the treatment of degenerative diseases of the retina |
| US7309487B2 (en) * | 2004-02-09 | 2007-12-18 | George Inana | Methods and compositions for detecting and treating retinal diseases |
| US7893315B2 (en) | 2004-11-04 | 2011-02-22 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells and embryo-derived cells |
| WO2006052646A2 (en) | 2004-11-04 | 2006-05-18 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells |
| ZA200901914B (en) * | 2006-09-22 | 2010-06-30 | Riken | Stem cell culture medium and method |
| DK2209888T3 (da) * | 2007-10-12 | 2020-01-20 | Astellas Inst For Regenerative Medicine | Forbedrede fremgangsmåder til fremstilling af rpe-celler og sammensætninger af rpe-celler |
| GB0806746D0 (en) | 2008-04-14 | 2008-05-14 | Ucl Business Plc | Membrane |
| BRPI0910575A2 (pt) * | 2008-04-18 | 2017-06-06 | Arizona Board Of Regents A Body Corp Of The State Of Arizona Acting For And Behalf Of The Univ Of Ar | métodos para tratar degeneração macular relacionada com a idade, para limitar desenvolvimento de degeneração macular relacionada com a idade, e para identificar compostos para tratar degeneração macular relacionada com a idade, e, composição |
| KR20120102709A (ko) * | 2009-11-17 | 2012-09-18 | 어드밴스드 셀 테크놀로지, 인코포레이티드 | 인간 ｒｐｅ 세포의 생산 방법 및 인간 ｒｐｅ 세포의 제약 제제 |
| WO2012012803A2 (en) * | 2010-07-23 | 2012-01-26 | Advanced Cell Technology, Inc. | Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
| US20110052678A1 (en) * | 2010-11-05 | 2011-03-03 | Shantha Totada R | Method for treating age related macular degeneration |
| WO2012135621A2 (en) | 2011-03-30 | 2012-10-04 | Cellular Dynamics International. Inc | Priming of pluripotent stem cells for neural differentiation |
| ES2722207T3 (es) * | 2011-04-29 | 2019-08-08 | Univ Southern California | Procedimientos para la crioconservación de células epiteliales de pigmento retiniano derivadas de citoblastos crecidas sobre un sustrato polimérico |
| TW202434266A (zh) | 2011-11-14 | 2024-09-01 | 安斯泰來再生醫藥協會 | 人類rpe細胞之醫藥組合物及其用途 |
| EP3189135B1 (en) * | 2014-09-05 | 2021-06-02 | Astellas Institute for Regenerative Medicine | Retinal ganglion cells and progenitors thereof |
-
2012
- 2012-11-14 TW TW113103167A patent/TW202434266A/zh unknown
- 2012-11-14 EP EP19164689.2A patent/EP3563860A1/en active Pending
- 2012-11-14 JP JP2014541421A patent/JP6506023B2/ja active Active
- 2012-11-14 HU HUE12848968 patent/HUE044778T2/hu unknown
- 2012-11-14 AU AU2012340020A patent/AU2012340020A1/en not_active Abandoned
- 2012-11-14 EP EP12848968.9A patent/EP2780022B2/en active Active
- 2012-11-14 CN CN202110854081.1A patent/CN113786417A/zh active Pending
- 2012-11-14 RS RS20190890A patent/RS59050B1/sr unknown
- 2012-11-14 GB GB1220511.8A patent/GB2496969A/en not_active Withdrawn
- 2012-11-14 FI FIEP12848968.9T patent/FI2780022T4/fi active
- 2012-11-14 IL IL308205A patent/IL308205B2/en unknown
- 2012-11-14 US US13/676,999 patent/US20130195806A1/en not_active Abandoned
- 2012-11-14 TW TW107102515A patent/TWI719277B/zh active
- 2012-11-14 LT LTEP12848968.9T patent/LT2780022T/lt unknown
- 2012-11-14 WO PCT/US2012/065091 patent/WO2013074681A1/en not_active Ceased
- 2012-11-14 TW TW109136186A patent/TWI785403B/zh active
- 2012-11-14 CA CA2855941A patent/CA2855941A1/en active Pending
- 2012-11-14 PL PL12848968T patent/PL2780022T3/pl unknown
- 2012-11-14 ES ES12848968T patent/ES2734453T3/es active Active
- 2012-11-14 TW TW101142511A patent/TWI655286B/zh active
- 2012-11-14 DK DK12848968.9T patent/DK2780022T4/da active
- 2012-11-14 SI SI201231636T patent/SI2780022T1/sl unknown
- 2012-11-14 HK HK15103225.4A patent/HK1202456A1/xx unknown
- 2012-11-14 PT PT12848968T patent/PT2780022T/pt unknown
- 2012-11-14 KR KR1020147016228A patent/KR102054904B1/ko not_active Expired - Fee Related
- 2012-11-14 CN CN201280066325.9A patent/CN104080464A/zh active Pending
- 2012-11-14 IL IL320536A patent/IL320536A/en unknown
- 2012-11-14 TW TW111133463A patent/TWI842079B/zh active
- 2012-11-14 IL IL287381A patent/IL287381B2/en unknown
- 2012-11-14 CA CA3178098A patent/CA3178098A1/en active Pending
- 2012-11-14 HR HRP20191110TT patent/HRP20191110T1/hr unknown
-
2014
- 2014-05-13 IL IL232600A patent/IL232600B/en active IP Right Grant
-
2015
- 2015-05-15 US US14/713,108 patent/US20150366915A1/en not_active Abandoned
-
2017
- 2017-09-08 AU AU2017225146A patent/AU2017225146C1/en active Active
- 2017-09-25 JP JP2017183914A patent/JP6563996B2/ja active Active
-
2019
- 2019-02-20 AU AU2019201201A patent/AU2019201201B2/en active Active
- 2019-05-27 JP JP2019098508A patent/JP6899865B2/ja active Active
- 2019-07-09 CY CY20191100720T patent/CY1121819T1/el unknown
-
2020
- 2020-03-05 IL IL273107A patent/IL273107B/en unknown
- 2020-07-13 US US16/927,068 patent/US20200405767A1/en not_active Abandoned
-
2021
- 2021-03-24 JP JP2021049493A patent/JP7081016B2/ja active Active
- 2021-07-06 AU AU2021204719A patent/AU2021204719B2/en active Active
-
2022
- 2022-05-25 JP JP2022084915A patent/JP7404441B2/ja active Active
-
2023
- 2023-12-13 JP JP2023209915A patent/JP7716463B2/ja active Active
-
2024
- 2024-10-10 US US18/911,566 patent/US20250134932A1/en active Pending
-
2025
- 2025-02-21 AU AU2025201277A patent/AU2025201277A1/en active Pending
- 2025-07-18 JP JP2025120956A patent/JP2025161815A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024037864A5 (enExample) | ||
| EP3139914B1 (en) | Compounds for treating ophthalmic diseases and disorders | |
| IL308205B1 (en) | Pharmaceutical preparations of human rpe cells and uses thereof | |
| CN101810563B (zh) | 他克莫司眼用在体凝胶制剂及其制备方法 | |
| TW200410699A (en) | Use of ANECORTAVE acetate for the protection of visual acuity in patients with age related macular degeneration | |
| JP2016121163A (ja) | 眼内でのコルチコステロイド使用に伴う眼圧の発生を減少させる方法 | |
| CN113577083A (zh) | 一种小分子化合物组合在制备预防和治疗视网膜损伤性疾病药物中的应用 | |
| US20240366565A1 (en) | Use of Verteporfin to Modulate Wound Healing After an Ocular Surgical Procedure or Ocular Injury | |
| US9636364B2 (en) | Methods for treating ocular contusion and blunt injury and traumatic injury to the optic nerve | |
| Rizzo et al. | Safety results for geographic atrophy associated with age-related macular degeneration using subretinal cord blood platelet-rich plasma | |
| WO2020228743A1 (zh) | 干细胞和细胞因子的组合及其在改善精子活力的用途 | |
| JP3310994B2 (ja) | アレルギー治療剤 | |
| CN113521309B (zh) | 人肝细胞生长因子基因在湿疹治疗中的应用及微针药械 | |
| CN102920722A (zh) | 治疗眼底病的眼用制剂 | |
| CN113786380A (zh) | 一种硝酸毛果芸香碱眼用凝胶及其制备方法 | |
| CN117338700B (zh) | 功能水凝胶及其制备和在制备治疗青光眼药物中的应用 | |
| Yang et al. | Case report: subconjunctival injection with autologous platelet-rich plasma for refractory corneal ulcers in a dog | |
| WO2025040177A1 (zh) | 一种适用于耳鼓给药的地塞米松磷酸钠冻干组合物及其制备方法 | |
| KR102860024B1 (ko) | 이나보글리플로진을 포함하는 안질환의 예방 또는 치료용 약학적 조성물 | |
| CN120227379A (zh) | 芦可替尼在治疗年龄相关性黄斑变性中的应用 | |
| JP2024528700A (ja) | 細胞喪失を治療又は阻害するためのヒスタチンの組み合わせ及び方法 | |
| CN103845330A (zh) | 一类降低眼压的化合物及其用途 | |
| RU2185176C2 (ru) | Способ лечения дистрофических заболеваний роговицы и болезни трансплантата роговицы | |
| JP2001072591A (ja) | 網膜神経細胞保護剤 | |
| Sun et al. | Single subconjunctival injection formulation using sol-gel mesoporous silica as a controlled release system for drop-free post-cataract surgery care |